Company Analysis

Axogen, Inc. (AXGN)

Nasdaq: AXGN · Electromedical & Electrotherapeutic Apparatus · Alachua, FL · filing with the SEC since 1995
Grade6.1
◀ Past 6.4● Present 6.6▶ Future 5.1
1 est.

Filings

294 filings since 2017 beside 554 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 28 days after the quarter ended. The proxy statement was last filed Apr 29, 2026.

Filings a yearinsider forms included
771049783678110769
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest Dec 5, 2025.SEC letters: 3 in the last 36 months, the newest Apr 26, 2024.
Insider forms 554

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 9, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Oct 28, 2026 10-Q Quarterly report Sep 30, 2026
Oct 28, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Oct 2, 2026 SCHEDULE 13G Large holder notice
Oct 1, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 10, 2026 424B5 Shelf offering
Sep 10, 2026 8-K/A items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report, amended Sep 9, 2026
Sep 10, 2026 8-K items 1.01, 7.01, 8.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD); Other event · Current report Sep 9, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 31, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 29, 2026 10-Q Quarterly report Jun 30, 2026
Jul 29, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jun 23, 2026 8-K item 5.07 Shareholder vote · Current report
May 7, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 29, 2026 SCHEDULE 13G Large holder notice
Apr 29, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 29, 2026 DEF 14A Proxy statement Dec 31, 2025
Apr 28, 2026 10-Q Quarterly report Mar 31, 2026
Apr 28, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Mar 26, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 24, 2026 10-K Annual report Dec 31, 2025
Feb 24, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jan 23, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Jan 21, 2026
Jan 23, 2026 424B5 Shelf offering
Jan 21, 2026 424B5 Shelf offering
Jan 21, 2026 S-3ASR Shelf registration
Jan 12, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Dec 5, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Dec 3, 2025
Dec 4, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Dec 3, 2025
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Oct 29, 2025 10-Q Quarterly report Sep 30, 2025
Oct 29, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Aug 25, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Aug 22, 2025
Aug 5, 2025 S-8 Employee stock plan registration
Aug 5, 2025 10-Q Quarterly report Jun 30, 2025
Aug 5, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jun 20, 2025 8-K items 5.07, 9.01 Shareholder vote · Current report Jun 18, 2025
May 15, 2025 SCHEDULE 13G/A Large holder update, amended
May 8, 2025 10-Q Quarterly report Mar 31, 2025
May 8, 2025 8-K items 2.02, 5.02, 9.01 Results released; Officer or director change · Current report
40 of 294 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton AXGN · research, not advice